Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - FREE CASH FLOW
Free Cash Flow DNLI - Denali Therapeutics Inc.
-371 M
LAST VALUE
-29.88%
2 YEAR CAGR
-54.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR